Hepatitis B co-infection in HIV-infected patients receiving antiretroviral therapy at the TC Newman Anti Retroviral Treatment Clinic in Paarl, Western Cape

Southern African Journal of HIV Medicine

Volumn 17, Issue 1, 2016, Pages

  King, Jeanmari ^a,b   Hagemeister, Dirk T ^c,d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b WESTERN CAPE DEPARTMENT OF HEALTH   (South Africa)

^c UNIVERSITY OF THE FREE STATE   (South Africa)

^d Department of Otorhinolaryngology   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; REVIEW; SCREENING TEST; SEX DIFFERENCE; SOUTH AFRICA; TREATMENT DURATION;

EID: 84992426198     PISSN: 16089693     EISSN: 20786751     Source Type: Journal    
DOI: 10.4102/sajhivmed.v17i1.336     Document Type: Review

References (15)

1. Kourtis AP, Bulterys M, Hu DJ, Jamieson DJ. HIV-HBV coinfection - A global challenge. N Engl J Med. 2012;366(19):1749-1752.
2. Soriano V, Puoti M, Peters M, et al. Care of HIV patients with chronic hepatitis B: Updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS. 2008;22(12):1399-1410.
3. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359(14):1486-1500.
4. Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS Lond Engl. 2005;9(6):593-601.
5. Kellerman SE, Hanson DL, McNaghten AD, Fleming PL. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis. 2003;88(4):571-577.
6. Hoffmann CJ, Charalambous S, Martin DJ, et al. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis. 2008;47(11):1479-1485.
7. Firnhaber C, Reyneke A, Schulze D, et al. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J. 2008;98(7):541-544.
8. Mayaphi SH, Rossouw TM, Masemola DP, Olorunju SA, Mphahlele MJ, Martin DJ. HBV/HIV co-infection: The dynamics of HBV in South African patients with AIDS. S Afr Med J. 2012;102(3):157-162.
9. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol. 2009;81(3):406-412.
10. Boyles TH, Cohen K. The prevalence of hepatitis B infection in a rural South African HIV clinic. S Afr Med J. 2011;101(7):470-471.
11. Dore GJ, Cooper DA, Pozniak AL, et al. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and-experienced patients coinfected with HIV-1 and hepatitis B virus. J Infect Dis. 2004;189(7):1185-1192.
12. Spearman CWN, Sonderup MW, Botha JF, et al. South African guideline for the management of chronic hepatitis B: 2013. S Afr Med J [serial online]. 2013 [cited 2015 Sep 19]; 103(5). Available from: http://hmpg.co.za/index.php/samj/article/view/3333
13. Department of Health of the Western Cape. ARV treatment: Substitution of tenofovir in place of stavudine and/or zidovudine: Baseline screening for hepatitis B chronic infection in patients starting antiretroviral treatment. Circular no H81/08. Cape Town: Department of Health; 2008.
14. Meintjes G, Black J, Conradie F. Guideline - Adult antiretroviral therapy guidelines 2014 - By the Southern African HIV Clinicians Society. S Afr J HIV Med. 2014; 15(4):121-143.
15. Republic of South Africa. Department of Health. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults - 24 December 2014 [homepage on the Internet]. 2014 [cited 2015 Sep 19]. Available from: www.health.gov.za/index.php/2014-03-17-09-09-38/policies-and-guidelines/category/230-2015p?download=937:national-art-guidelines-2015final